← FDA DRUG APPROVALS

FDA ANDA · ANDA061699

BACITRACIN

Sponsor: APOTHEKERNES

APPLICATION
ANDA061699
TYPE
ANDA
ORIGINAL APPROVAL
1972-12-21
LATEST ACTION
1972-12-21
ROUTE
FOR RX COMPOUNDING
DOSAGE FORM
POWDER
MARKETING STATUS
Discontinued

Products

BACITRACINDiscontinued
BACITRACIN 5,000,000 UNITS/BOT · POWDER · FOR RX COMPOUNDING

Approval history

1972-12-21OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →